Blood biopsy study aims to improve cancer detection and monitoring

NCT ID NCT05089747

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at special markers in the blood (called biomarkers) to learn more about how to detect, diagnose, and track solid cancers. Researchers will collect blood samples from 6,000 adults with solid cancer and analyze them alongside standard tests. The goal is to see if these blood tests can help doctors better understand cancer and make more informed treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT WITH SOLID CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Edouard Herriot / Groupement Hospitalier Centre

    RECRUITING

    Lyon, 69003, France

  • Hôpital Lyon-Sud / Groupement Hospitalier Sud

    RECRUITING

    Pierre-Bénite, 69495, France

  • Oncologie médicale Hôpital Lyon-Sud / Groupement Hospitalier Sud

    RECRUITING

    Pierre-Bénite, 69495, France

  • Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique Hôpital Lyon-Sud / Groupement Hospitalier Sud

    RECRUITING

    Pierre-Bénite, 69310, France

  • Service de Pneumologie Hôpital Croix-Rousse / Groupement Hospitalier Nord

    RECRUITING

    Lyon, 69004, France

  • Service de Pneumologie Hôpital Louis Pradel / Groupement Hospitalier Est

    RECRUITING

    Bron, 69500, France

  • Service de dermatologie Hôpital Lyon-Sud / Groupement Hospitalier Sud

    RECRUITING

    Pierre-Bénite, 69495, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.